A comparative study of the safety and efficacy of 75% mulberry (Morus alba) extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22052272
Conclusion of this study
The mean MASI score significantly improved from 4.076 (± 0.24) at baseline to 2.884 (± 0.25) at week 8 for the 75% mulberry extract oil group while the placebo group showed an improvement of a lesser magnitude.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study